Role of host sphingosine kinase 1 in the lung response against cryptococcosis

Infection and Immunity

Volumn 78, Issue 5, 2010, Pages 2342-2352

  McQuiston, Travis ^a   Luberto, Chiara ^a   Del Poeta, Maurizio ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDE; SPHINGOSINE KINASE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BRAIN INFECTION; CELL WALL; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL VIRULENCE; HISTOPATHOLOGY; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION CONTROL; LUNG; LUNG ALVEOLUS MACROPHAGE; LUNG GRANULOMA; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; COLONY COUNT, MICROBIAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GRANULOMA; LUNG; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SURVIVAL ANALYSIS;

EID: 77951216949     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01140-09     Document Type: Article

References (50)

1. Allende, M. L., T. Sasaki, H. Kawai, A. Olivera, Y. Mi, G. van Echten- Deckert, R. Hajdu, M. Rosenbach, C. A. Keohane, S. Mandala, S. Spiegel, and R. L. Proia. 2004. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J. Biol. Chem. 279:52487-52492.
2. Ammit, A. J., A. T. Hastie, L. C. Edsall, R. K. Hoffman, Y. Amrani, V. P. Krymskaya, S. A. Kane, S. P. Peters, R. B. Penn, S. Spiegel, and R. A. Panettieri, Jr. 2001. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 15:1212-1214.
3. Argraves, K. M., P. J. Gazzolo, E. M. Groh, B. A. Wilkerson, B. S. Matsuura, W. O. Twal, S. M. Hammad, and W. S. Argraves. 2008. High density lipoprotein- associated sphingosine 1-phosphate promotes endothelial barrier function. J. Biol. Chem. 283:25074-25081.
4. Billich, A., F. Bornancin, P. Devay, D. Mechtcheriakova, N. Urtz, and T. Baumruker. 2003. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J. Biol. Chem. 278:47408-47415.
5. Clancy, C. J., M. H. Nguyen, R. Alandoerffer, S. Cheng, K. Iczkowski, M. Richardson, and J. R. Graybill. 2006. Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors. Microbiology 152:2247-2255.
6. Diamond, R. D., and J. E. Bennett. 1973. Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans. J. Infect. Dis. 127:694-697.
7. Duong, C. Q., S. M. Bared, A. Abu-Khader, C. Buechler, A. Schmitz, and G. Schmitz. 2004. Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages. Biochim. Biophys. Acta 1682:112-119.
8. Duong, M., N. Ouellet, M. Simard, Y. Bergeron, M. Olivier, and M. G. Bergeron. 1998. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J. Infect. Dis. 178:1472-1482.
9. Feldmesser, M., A. Casadevall, Y. Kress, G. Spira, and A. Orlofsky. 1997. Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro. Infect. Immun. 65:1899-1907.
10. Feldmesser, M., Y. Kress, and A. Casadevall. 2001. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147:2355-2365. (Pubitemid 32785515)
11. Feldmesser, M., Y. Kress, and A. Casadevall. 2001. Intracellular crystal formation as a mechanism of cytotoxicity in murine pulmonary Cryptococcus neoformans infection. Infect. Immun. 69:2723-2727.
12. Feldmesser, M., Y. Kress, P. Novikoff, and A. Casadevall. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68:4225-4237.
13. Feldmesser, M., S. Tucker, and A. Casadevall. 2001. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 9:273-278. (Pubitemid 32522807)
14. Futerman, A. H., and Y. A. Hannun. 2004. The complex life of simple sphingolipids. EMBO Rep. 5:777-782.
15. Garcia-Hermoso, D., F. Dromer, and G. Janbon. 2004. Cryptococcus neoformans capsule structure evolution in vitro and during murine infection. Infect. Immun. 72:3359-3365.
16. Garg, S. K., M. B. Santucci, M. Panitti, L. Pucillo, M. Bocchino, F. Okajima, P. S. Bisen, C. Saltini, and M. Fraziano. 2006. Does sphingosine 1-phosphate play a protective role in the course of pulmonary tuberculosis? Clin. Immunol. 121:260-264.
17. Garg, S. K., E. Volpe, G. Palmieri, M. Mattei, D. Galati, A. Martino, M. S. Piccioni, E. Valente, E. Bonanno, P. De Vito, P. M. Baldini, L. G. Spagnoli, V. Colizzi, and M. Fraziano. 2004. Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo. J. Infect. Dis. 189:2129-2138.
18. Gellings Lowe, N., J. S. Swaney, K. M. Moreno, and R. A. Sabbadini. 2009. Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts. Cardiovasc. Res. 82:303-312.
19. Guo, L., R. S. Johnson, and J. C. Schuh. 2000. Biochemical characterization of endogenously formed eosinophilic crystals in the lungs of mice. J. Biol. Chem. 275:8032-8037.
20. Hammad, S. M., H. G. Crellin, B. X. Wu, J. Melton, V. Anelli, and L. M. Obeid. 2008. Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages. Prostaglandins Other Lipid Mediat. 85:107-114.
21. Huffnagle, G. B., M. B. Boyd, N. E. Street, and M. F. Lipscomb. 1998. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J. Immunol. 160:2393-2400.
22. Jolly, P. S., H. M. Rosenfeldt, S. Milstien, and S. Spiegel. 2002. The roles of sphingosine-1-phosphate in asthma. Mol. Immunol. 38:1239-1245.
23. Jung, I. D., J. S. Lee, Y. J. Kim, Y. I. Jeong, C. M. Lee, T. Baumruker, A. Billlich, Y. Banno, M. G. Lee, S. C. Ahn, W. S. Park, J. Han, and Y. M. Park. 2007. Sphingosine kinase inhibitor suppresses a Th1 polarization via the inhibition of immunostimulatory activity in murine bone marrow-derived dendritic cells. Int. Immunol. 19:411-426.
24. Kechichian, T. B., J. Shea, and M. Del Poeta. 2007. Depletion of alveolar macrophages decreases the dissemination of a glucosylceramide-deficient mutant of Cryptococcus neoformans in immunodeficient mice. Infect. Immun. 75:4792-4798.
25. Kim, R. H., K. Takabe, S. Milstien, and S. Spiegel. 2009. Export and functions of sphingosine-1-phosphate. Biochim. Biophys. Acta 1791:692-696.
26. Lai, W. Q., A. W. Irwan, H. H. Goh, A. J. Melendez, I. B. McInnes, and B. P. Leung. 2009. Distinct roles of sphingosine kinase 1 and 2 in murine collagen-induced arthritis. J. Immunol. 183:2097-2103.
27. Levitz, S. M. 2002. Receptor-mediated recognition of Cryptococcus neoformans. Nippon Ishinkin Gakkai Zasshi 43:133-136.
28. Levitz, S. M., S. H. Nong, K. F. Seetoo, T. S. Harrison, R. A. Speizer, and E. R. Simons. 1999. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67:885-890.
29. 2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase. J. Immunol. 170:2811-2815.
30. Melendez, A., R. A. Floto, D. J. Gillooly, M. M. Harnett, and J. M. Allen. 1998. FcγRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. J. Biol. Chem. 273: 9393-9402.
31. Melendez, A. J., E. Carlos-Dias, M. Gosink, J. M. Allen, and L. Takacs. 2000. Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution. Gene 251:19-26. (Pubitemid 30339413)
32. 2+ signals, enzyme release, cytokine production, and chemotaxis. J. Immunol. 173:1596-1603.
33. Milam, J. E., A. C. Herring-Palmer, R. Pandrangi, R. A. McDonald, G. B. Huffnagle, and G. B. Toews. 2007. Modulation of the pulmonary type 2 T-cell response to Cryptococcus neoformans by intratracheal delivery of a tumor necrosis factor alpha-expressing adenoviral vector. Infect. Immun. 75:4951-4958.
34. Nemzek, J. A., G. L. Bolgos, B. A. Williams, and D. G. Remick. 2001. Differences in normal values for murine white blood cell counts and other hematological parameters based on sampling site. Inflamm. Res. 50:523-527.
35. Oskeritzian, C. A., S. Milstien, and S. Spiegel. 2007. Sphingosine-1-phosphate in allergic responses, asthma and anaphylaxis. Pharmacol. Ther. 115: 390-399.
36. Rittershaus, P. C., T. B. Kechichian, J. C. Allegood, A. H. Merrill, Jr., M. Hennig, C. Luberto, and M. Del Poeta. 2006. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans. J. Clin. Invest. 116:1651-1659.
37. Rivera, J., and A. Casadevall. 2005. Mouse genetic background is a major determinant of isotype-related differences for antibody-mediated protective efficacy against Cryptococcus neoformans. J. Immunol. 174:8017-8026. (Pubitemid 40806313)
38. Rosenfeldt, H. M., Y. Amrani, K. R. Watterson, K. S. Murthy, R. A. Panettieri, Jr., and S. Spiegel. 2003. Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells. FASEB J. 17:1789-1799. (Pubitemid 37214773)
39. Sali, M., G. Delogu, E. Greco, S. Rocca, V. Colizzi, G. Fadda, and M. Fraziano. 2009. Exploiting immunotherapy in Mycobacterium tuberculosis-infected mice: sphingosine 1-phosphate treatment results in a protective or detrimental effect depending on the stage of infection. Int. J. Immunopathol. Pharmacol. 22:175-181.
40. Santucci, M. B., E. Greco, M. De Spirito, G. Arcovito, G. De Angelis, R. Cauda, and M. Fraziano. 2007. Sphingosine 1-phosphate promotes antigen processing and presentation to CD4+ T cells in Mycobacterium tuberculosis- infected monocytes. Biochem. Biophys. Res. Commun. 361:687-693.
41. Schnell, M. A., C. Hardy, M. Hawley, K. J. Propert, and J. M. Wilson. 2002. Effect of blood collection technique in mice on clinical pathology parameters. Hum. Gene Ther. 13:155-161.
42. Shea, J. M., and M. Del Poeta. 2006. Lipid signaling in pathogenic fungi. Curr. Opin. Microbiol. 9:352-358.
43. Silva, M. T. 28 January 2010, posting date. Neutrophils and macrophages work in concert as inducers and effectors of adaptive immunity against extracellular and intracellular microbial pathogens. J. Leukoc. Biol. [Epub ahead of print.]
44. Snider, A. J., T. Kawamori, S. G. Bradshaw, K. A. Orr, G. S. Gilkeson, Y. A. Hannun, and L. M. Obeid. 2009. A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis. FASEB J. 23:143-152.
45. Taborda, C. P., and A. Casadevall. 2002. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 16:791-802.
46. Thompson, C. R., S. S. Iyer, N. Melrose, R. VanOosten, K. Johnson, S. M. Pitson, L. M. Obeid, and D. J. Kusner. 2005. Sphingosine kinase 1 (SK1) is recruited to nascent phagosomes in human macrophages: inhibition of SK1 translocation by Mycobacterium tuberculosis. J. Immunol. 174:3551-3561.
47. Urata, Y., Y. Nishimura, T. Hirase, and M. Yokoyama. 2005. Sphingosine 1-phosphate induces alpha-smooth muscle actin expression in lung fibroblasts via Rho-kinase. Kobe J. Med. Sci. 51:17-27.
48. Yadav, M., L. Clark, and J. S. Schorey. 2006. Macrophage's proinflammatory response to a mycobacterial infection is dependent on sphingosine kinase-mediated activation of phosphatidylinositol phospholipase C, protein kinase C, ERK1/2, and phosphatidylinositol 3-kinase. J. Immunol. 176:5494-5503.
49. 2+ signaling. J. Dermatol. Sci. 51:89-102.
50. Zhi, L., B. P. Leung, and A. J. Melendez. 2006. Sphingosine kinase 1 regulates proinflammatory responses triggered by TNFα in primary human monocytes. J. Cell. Physiol. 208:109-115.